Insulin Degludec And Liraglutide has 43 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Acidifying Agents, Albuterol, Alcohol. Patients taking Insulin Degludec And Liraglutide should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 43
- Moderate
- 41
Moderate (41)
- Insulin Degludec And Liraglutide + Acidifying Agents— May increase risk of hypoglycemia; dosage reductions and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Albuterol— Sympathomimetic agent that may decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring…
- Insulin Degludec And Liraglutide + Alcohol— May increase or decrease blood glucose-lowering effect; dosage adjustment and increased glucose monitoring may be requir…
- Insulin Degludec And Liraglutide + Amiloride Hydrochloride And Hydrochlorothiazide— Dosage adjustment of the antidiabetic drug may be required when used with hydrochlorothiazide.
- Insulin Degludec And Liraglutide + Angiotensin Ii— May increase risk of hypoglycemia; dosage reductions and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Candesartan Cilexetil And Hydrochlorothiazide— Dosage adjustment of the antidiabetic drug may be required.
- Insulin Degludec And Liraglutide + Chlorothiazide Sodium— Dosage adjustment of the antidiabetic drug may be required when used concurrently with chlorothiazide sodium.
- Insulin Degludec And Liraglutide + Clonidine— May increase or decrease blood glucose-lowering effect and may blunt signs/symptoms of hypoglycemia; dosage adjustment a…
- Insulin Degludec And Liraglutide + Clozapine— Atypical antipsychotic that may decrease blood glucose-lowering effect; dosage increases and increased glucose monitorin…
- Insulin Degludec And Liraglutide + Corticosteroids— May decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Danazol— May decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Disopyramide— May increase risk of hypoglycemia; dosage reductions and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Diuretics— May decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Epinephrine— Sympathomimetic agent that may decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring…
- Insulin Degludec And Liraglutide + Estrogens— May decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Fibrates— May increase risk of hypoglycemia; dosage reductions and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Fluoxetine— May increase risk of hypoglycemia; dosage reductions and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Glucagon— May decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Guanethidine— May blunt signs and symptoms of hypoglycemia; increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Hydrochlorothiazide— Dosage adjustment of the antidiabetic drug may be required when used with hydrochlorothiazide.
- Insulin Degludec And Liraglutide + Irbesartan And Hydrochlorothiazide— Dosage adjustment of antidiabetic drug may be required when coadministered with hydrochlorothiazide.
- Insulin Degludec And Liraglutide + Isoniazid— May decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Lithium— May increase or decrease blood glucose-lowering effect; dosage adjustment and increased glucose monitoring may be requir…
- Insulin Degludec And Liraglutide + Macrolide Antibiotics— May increase risk of hypoglycemia; dosage reductions and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Mao Inhibitors— May increase risk of hypoglycemia; dosage reductions and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Monoamine Oxidase Inhibitors (Maois)— May increase risk of hypoglycemia; dosage reductions and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Niacin— May decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Nonselective Beta-Adrenergic Antagonists— May increase or decrease blood glucose-lowering effect and may blunt signs/symptoms of hypoglycemia; dosage adjustment a…
- Insulin Degludec And Liraglutide + Octreotide— Somatostatin analog that may increase risk of hypoglycemia; dosage reductions and increased glucose monitoring may be re…
- Insulin Degludec And Liraglutide + Olanzapine— Atypical antipsychotic that may decrease blood glucose-lowering effect; dosage increases and increased glucose monitorin…
- Insulin Degludec And Liraglutide + Oral Contraceptives— May decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Pentamidine— May cause hypoglycemia followed sometimes by hyperglycemia; dosage adjustment and increased glucose monitoring may be re…
- Insulin Degludec And Liraglutide + Pentoxifylline— May increase risk of hypoglycemia; dosage reductions and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Phenothiazines— May decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Pramlintide— May increase risk of hypoglycemia; dosage reductions and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Protease Inhibitors— May decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Reserpine— May blunt signs and symptoms of hypoglycemia; increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Salicylates— May increase risk of hypoglycemia; dosage reductions and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Somatropin— May decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring may be required.
- Insulin Degludec And Liraglutide + Terbutaline— Sympathomimetic agent that may decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring…
- Insulin Degludec And Liraglutide + Thyroid Hormones— May decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring may be required.